Evidence of antisense tumor targeting in mice

Bioconjugate Chemistry

Volumn 15, Issue 6, 2004, Pages 1475-1480

  Nakamura, K ^a   Fan, C ^b,c   Liu, G ^b   Gupta, S ^b   He, J ^b   Dou, S ^b   Kubo, A ^a   Rusckowski, M ^b   Hnatowich, D J ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; IMAGE ENHANCEMENT; MAMMALS; NANOWIRES; POLYMERASE CHAIN REACTION; TUMORS;

ANTISENSE; BIODISTRIBUTIONS; CELL LINES; IN-VIVO; INTRAVENOUS ADMINISTRATION; NORMAL TISSUE; NUDE MICE; STATISTICALLY SIGNIFICANT DIFFERENCE; TUMOR-TARGETING; TUMOUR CELLS;

DNA;

COMPLEMENTARY DNA; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG TUMOR LEVEL; GENE TARGETING; HEART; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY; LARGE INTESTINE; LUNG DEAD SPACE; MOUSE; NONHUMAN; NUDE MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; SPLEEN; TISSUE DISTRIBUTION;

ANIMALIA; MUS MUSCULUS;

EID: 9244265000     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0499073     Document Type: Conference Paper

References (20)

1. Hnatowich, D. J. (1999) Antisense and Nuclear Medicine. J. Nucl. Med. 40, 693-703.
2. 99mTc-labeled antisense DNA. J. Nucl. Med. 42, 1660-1669.
3. 99mTc- antisense oligonucleotides in target tumor cells. Cancer Biother. Radiopharm. 16, 411-419.
4. Nakamura, K., Liu, G., Zhang, Y., Kubo, A., and Hnatowich, D. J. (2003) Antisense targeting of P-glycoprotein MDR expression in tissue culture. J. Nucl. Med. 44, 304 (Abstract).
5. Alahari, S. K., DeLong, R., Fisher, M. H., Dean, N. M., Viliet, P., and Juliano, R. L. (1998) Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression. J. Pharm. Exp. Ther. 286, 419-428.
6. 3 for technetium-99m labeling of DNA. Nucl. Med. Biol. 24, 425-432.
7. 3-conjugated morpholino oligomers. Bioconjugate Chem. 13, 893-897.
8. Chen, C., and Smith, B. J. (2003) Utility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery. Curr. Drug Metab. 4, 272-291.
9. Hnatowich, D. J. (2000) Antisense and Nuclear Medicine. Where are we now? Cancer Biother. Radiopharm. 15, 447-457.
10. Lewis, M. R., and Jia, F. (2003) Antisense imaging: and miles to go before we sleep? J. Cell Biochem. 90, 464-474.
11. Younes, C. K., Boisgard, R., and Tavitian, B. (2002) Labeled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Curr. Pharm. Des. 8, 1451-1466.
12. WAF-1/CIP-1 gene expression in MDA-MB-468 human breast cancer xenografts Eur. J. Nucl. Med. Mol. Imaging 30, 1273-1280.
13. Lewis, M. R., Jia, F., Gallazzi, F., Wang, T., Zhang, J., Shenoy, N., Lever, S. Z., and Hannink, M. (2002) Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA binding. Bioconjugate Chem. 13, 1176-1180.
14. Sato, N., Kobayashi, H., Saga, T., Nakamoto, Y., Ishimori, T., Togashi, K., Fujibayashi, Y., Konishi, J., and Brechbiel, M. W. (2001) Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin. Cancer Res. 7, 3606-3612.
15. Wang, L., Prakash, R. H., Stein, C. A., Koehn, R. K., and Ruffner, D. E. (2003a) Progress in the delivery of therapeutic oligonucleotides: Organ/cellular distribution and targeted delivery of oligonucleotides in vivo. Antisense Nucleic Acid Drug Dev. 13, 169-189.
16. Lee, H. J., Boado, R. J., Braasch, D. A., Corey, D. R., and Partridge, W. M. (2002) Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. J. Nucl. Med. 43, 948-956.
17. 11C-labeled phosphorothioate oliogdeoxynucleotide. Neuroreport. 10, 2971-2974.
18. 68Ga-labeled oligonucleotides for in vivo imaging with PET J. Nucl. Med. 45, 347-355.
19. 99mTc-peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumors. Nuc. Med. Commun. 24, 857-863.
20. Dewanjee, M. K., Ghafouripour, A. K., Kapodvanjwala, M., Dewanjee, S., Sarafini, A. N., Lopez, D. M., and Sfakianakis, G. N. (1994) Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. Nucl. Med. 35, 1054-1063.